Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henri Xhaard

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 31, 2020
Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-κB activation, and decrease TNF-alpha secretion in primary microgliaMaiju Rinne, Kert Mätlik, Tiina Ahonen, et al.
Bioorganic & Medicinal Chemistry|March 5, 2018
Adenosine analogs bearing phosphate isosteres as human MDO1 ligandsYuezhou Zhang, Mikael Jumppanen, Mirko M Maksimainen, et al.
Journal of Medicinal Chemistry|August 22, 2019
Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction ModulatorsMikael Jumppanen, Sini M Kinnunen, Mika J Välimäki, et al.
European Journal of Medicinal Chemistry|April 13, 2018
Synthesis of 7β-hydroxy-8-ketone opioid derivatives with antagonist activity at mu- and delta-opioid receptorsTiina J Ahonen, Maiju Rinne, Peter Grutschreiber, et al.
Science Advances|May 28, 2019
Asymmetry in catalysis by <i>Thermotoga maritima</i> membrane-bound pyrophosphatase demonstrated by a nonphosphorus allosteric inhibitorKeni Vidilaseris, Alexandros Kiriazis, Ainoleena Turku, et al.
Chemmedchem|August 30, 2021
Exploration of Pyrazolo[1,5-a]pyrimidines as Membrane-Bound Pyrophosphatase InhibitorsNiklas G Johansson, Loïc Dreano, Keni Vidilaseris, et al.
Journal of Medicinal Chemistry|February 7, 2026
Rediscovering Diazaborines: Synthesis and Bioactivity Profiling of Boron-Containing FabI Inhibitors against Gram-Negative BacteriaPolina Ilina, Vladimir Iashin, Cristina D Cruz, et al.
Journal of Medicinal Chemistry|April 3, 2023
Expanding the Paradigm of Structure-Based Drug Design: Molecular Dynamics Simulations Support the Development of New Pyridine-Based Protein Kinase C-Targeted AgonistsSaara Lautala, Riccardo Provenzani, Ilari Tarvainen, et al.
Elife|November 13, 2025
Conformational dynamics and asymmetry in multimodal inhibition of membrane-bound pyrophosphatasesJianing Liu, Anokhi Shah, Xinyu Liu, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of Membrane-Bound Pyrophosphatase Inhibitors Derived from an Isoxazole FragmentNiklas G Johansson, Ainoleena Turku, Keni Vidilaseris, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 31, 2020
Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-κB activation, and decrease TNF-alpha secretion in primary microgliaMaiju Rinne, Kert Mätlik, Tiina Ahonen, et al.
Bioorganic & Medicinal Chemistry|March 5, 2018
Adenosine analogs bearing phosphate isosteres as human MDO1 ligandsYuezhou Zhang, Mikael Jumppanen, Mirko M Maksimainen, et al.
Journal of Medicinal Chemistry|August 22, 2019
Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction ModulatorsMikael Jumppanen, Sini M Kinnunen, Mika J Välimäki, et al.
European Journal of Medicinal Chemistry|April 13, 2018
Synthesis of 7β-hydroxy-8-ketone opioid derivatives with antagonist activity at mu- and delta-opioid receptorsTiina J Ahonen, Maiju Rinne, Peter Grutschreiber, et al.
Science Advances|May 28, 2019
Asymmetry in catalysis by <i>Thermotoga maritima</i> membrane-bound pyrophosphatase demonstrated by a nonphosphorus allosteric inhibitorKeni Vidilaseris, Alexandros Kiriazis, Ainoleena Turku, et al.
Chemmedchem|August 30, 2021
Exploration of Pyrazolo[1,5-a]pyrimidines as Membrane-Bound Pyrophosphatase InhibitorsNiklas G Johansson, Loïc Dreano, Keni Vidilaseris, et al.
Journal of Medicinal Chemistry|February 7, 2026
Rediscovering Diazaborines: Synthesis and Bioactivity Profiling of Boron-Containing FabI Inhibitors against Gram-Negative BacteriaPolina Ilina, Vladimir Iashin, Cristina D Cruz, et al.
Journal of Medicinal Chemistry|April 3, 2023
Expanding the Paradigm of Structure-Based Drug Design: Molecular Dynamics Simulations Support the Development of New Pyridine-Based Protein Kinase C-Targeted AgonistsSaara Lautala, Riccardo Provenzani, Ilari Tarvainen, et al.
Elife|November 13, 2025
Conformational dynamics and asymmetry in multimodal inhibition of membrane-bound pyrophosphatasesJianing Liu, Anokhi Shah, Xinyu Liu, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of Membrane-Bound Pyrophosphatase Inhibitors Derived from an Isoxazole FragmentNiklas G Johansson, Ainoleena Turku, Keni Vidilaseris, et al.
Pageof 7